Guerbet SA (GBT):企業の財務・戦略的SWOT分析

◆英語タイトル:Guerbet SA (GBT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4783
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Guerbet SA (GBT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Guerbet SA (Guerbet) operates in the contrast-agent field. The company provides a wide range of pharmaceutical products, medical equipments and services for interventional imaging and diagnostic, to improve the diagnosis and treatment of patients. Its major products include diagnostic imaging products comprising contrast media for X-Ray imaging and magnetic resonance imaging (MRI); delivery systems and services; and interventional imaging products. Guerbet has presence in Europe, Asia, Oceania and North and South America. The company offers products directly through its sales structure, distributors and license-holders. Guerbet is headquartered in Villepinte, France.

Guerbet SA Key Recent Developments

Jul 26,2018: GUERBET : Revenue at June 30 2018
Jul 10,2018: IBM Watson Health and Guerbet to use AI in medical imaging
Jul 09,2018: Guerbet Names Richard Hines as Head of Sales for New North American Interventional Imaging Division
Apr 18,2018: Guerbet reports 1st quarter 2018 revenue
Apr 18,2018: GEAR 2023 strategic plan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Guerbet SA – Key Facts 6
Guerbet SA – Key Employees 7
Guerbet SA – Key Employee Biographies 8
Guerbet SA – Major Products and Services 9
Guerbet SA – History 10
Guerbet SA – Company Statement 12
Guerbet SA – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 16
Company Overview 16
Guerbet SA – Business Description 17
Business Segment: Diagnostic Imaging 17
Overview 17
Performance 17
Key Stats 17
Business Segment: Interventional Imaging 17
Overview 17
Performance 18
Business Segment: Others 18
Performance 18
Geographical Segment: Europe 18
Performance 18
Geographical Segment: Other Markets 18
Performance 18
R&D Overview 18
Guerbet SA – Corporate Strategy 19
Guerbet SA – SWOT Analysis 20
SWOT Analysis – Overview 20
Guerbet SA – Strengths 20
Guerbet SA – Weaknesses 21
Guerbet SA – Opportunities 22
Guerbet SA – Threats 23
Guerbet SA – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 32
Guerbet SA, Medical Equipment, Deals By Type, 2012 to YTD 2018 33
Guerbet SA, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
Jul 26, 2018: GUERBET : Revenue at June 30 2018 35
Jul 10, 2018: IBM Watson Health and Guerbet to use AI in medical imaging 36
Jul 09, 2018: Guerbet Names Richard Hines as Head of Sales for New North American Interventional Imaging Division 37
Apr 18, 2018: Guerbet reports 1st quarter 2018 revenue 38
Apr 18, 2018: GEAR 2023 strategic plan 39
Mar 27, 2018: Guerbet: 2017 Annual Results – Satisfactory activity slightly exceeding the objectives 41
Feb 19, 2018: David Hale Appoints Guerbet Executive Committee as Chief Commercial Officer, Diagnostic Imaging 43
Feb 15, 2018: GUERBET : 2017 revenue at constant exchange rates: €812.4 million; +4.7% 44
Dec 06, 2017: Gadolinium-based contrast agents: update on MHLW decision in Japan 46
Oct 25, 2017: GUERBET: Revenue at September 30, 2017 48
Section 6 – Appendix 49
Methodology 49
Ratio Definitions 49
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Guerbet SA, Key Facts 6
Guerbet SA, Key Employees 7
Guerbet SA, Key Employee Biographies 8
Guerbet SA, Major Products and Services 9
Guerbet SA, History 10
Guerbet SA, Other Locations 13
Guerbet SA, Subsidiaries 13
Guerbet SA, Key Competitors 24
Guerbet SA, Ratios based on current share price 25
Guerbet SA, Annual Ratios 26
Guerbet SA, Annual Ratios (Cont...1) 27
Guerbet SA, Annual Ratios (Cont...2) 28
Guerbet SA, Interim Ratios 30
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 32
Guerbet SA, Medical Equipment, Deals By Type, 2012 to YTD 2018 33
Guerbet SA, Recent Deals Summary 34
Currency Codes 49
Capital Market Ratios 49
Equity Ratios 50
Profitability Ratios 50
Cost Ratios 51
Liquidity Ratios 51
Leverage Ratios 52
Efficiency Ratios 52

List of Figures
Guerbet SA, Performance Chart (2013 - 2017) 29
Guerbet SA, Ratio Charts 31
Guerbet SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 32
Guerbet SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 33

★海外企業調査レポート[Guerbet SA (GBT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • iCAD Inc (ICAD)-医療機器分野:企業M&A・提携分析
    Summary iCAD Inc (iCAD) is a medical device company. It develops and markets computer aided detection (CAD) solutions and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD produ …
  • New Age (African Global Energy) Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary New Age (African Global Energy) Ltd (New Age) is an oil and gas company that explores and develops oil and gas fields, and oil wells. The company provides activities such as include exploration, production, appraisal and development of oil and gas assets in seven sub Saharan African countrie …
  • GulfMark Offshore Inc (GLF):企業の財務・戦略的SWOT分析
    Summary GulfMark Offshore Inc (GulfMark Offshore), formerly New GulfMark Offshore Inc is an oil and gas company that offers oil and gas, and marine transportation services. It owns, operates, and manages fleet of vessels offering marine specialty services to offshore oil and natural gas drilling rig …
  • Genocea Biosciences Inc (GNCA):企業の財務・戦略的SWOT分析
    Summary Genocea Biosciences Inc (Genocea), formerly Genocea Inc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tec …
  • F. Hoffmann-La Roche Ltd:戦略・SWOT・企業財務分析
    F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report Summary F. Hoffmann-La Roche Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Apollo Consolidated Ltd (AOP):企業の財務・戦略的SWOT分析
    Summary Apollo Consolidated Ltd (Apollo) is a mining and mineral exploration company. The company’s business activities include acquisition, exploration, and development of gold, copper and nickel mineral deposits. Apollo holds exploration permits in Western Australia and Western Africa. The company …
  • LG Chem Ltd (051910):電力:M&Aディール及び事業提携情報
    Summary LG Chem Ltd (LG Chem) is a chemical manufacturer. It manufactures and markets petrochemicals, IT and electronic materials, and energy solutions. The company’s product portfolio comprises poly vinyl chloride (PVC), ethylene, propylene, butadiene, benzene, polarizer, glass substrate, semicondu …
  • Arrow Electronics Inc (ARW):企業の財務・戦略的SWOT分析
    Arrow Electronics Inc (ARW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Celonic AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that offers contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of acti …
  • PanAtlantic Exploration Co:企業の戦略的SWOT分析
    PanAtlantic Exploration Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Orange Polska S.A.:戦略・SWOT・企業財務分析
    Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Orange Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Svenska Petroleum Exploration AB:石油・ガス:M&Aディール及び事業提携情報
    Summary Svenska Petroleum Exploration AB (Svenska Petroleum), a subsidiary of Petroswede AB is an oil and gas company that offers offshore oil exploration and production. The company operates 3D Sendji data and acquisition of new 3D data in Kaba area to explore for the pre-salt. It has oil and gas p …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • FLIR Systems Inc:企業のM&A・事業提携・投資動向
    FLIR Systems Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FLIR Systems Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Ergon Energy Corporation Limited:企業の戦略・SWOT・財務分析
    Ergon Energy Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Ergon Energy Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Orange SA:戦略・SWOT・企業財務分析
    Orange SA - Strategy, SWOT and Corporate Finance Report Summary Orange SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Cembra Money Bank AG:企業の戦略・SWOT・財務情報
    Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report Summary Cembra Money Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Fresenius Kabi USA LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically il …
  • Arrow Energy Pty Ltd:企業の戦略的SWOT分析
    Arrow Energy Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆